Back to results
US 11,447,565 B2Granted
Method for treating a GD2 positive cancer
AssigneeApeiron Biologics AG
InventorsHans Loibner, Manfred Schuster, Evelyne Janzek-Hawlat, Susanne Wiederkum, Bernhard Peball, Stefan Stranner, Oliver Mutschlechner, Franz Groiss, Ruth Ladenstein, Holger Lode
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient as a continuous intravenous infusion over 24 hours per day.
Claims22
A method for treating a patient with a GD2 positive cancer comprising:
- administering a preparation comprising a anti-GD2 antibody to the patient as a continuous intravenous infusion over 24 hours per day at a daily dose of 10 mg/m2 for 10 consecutive days, wherein the anti-GD2 antibody is ch14.18/CHO or ch14.18/SP2/0;
- and
- administering IL-2, wherein administering the IL-2 precedes and/or at least partially accompanies the period of time of the administration of the preparation comprising the anti-GD2 antibody.
Dependencies are inferred from the claim text.